Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of Adherence to the Global Algorithm for Initial Crossing Strategy Selection in Chronic Total Occlusion Percutaneous Coronary Intervention.

The American journal of cardiology·2026

Same author

HydroDynamic Recanalization for Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Same author

Modification Procedures for Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2025

Same author

Multiple Versus Single Vessel CTO PCI in the Same Hospitalization: Data From the PROGRESS-CTO Registry.

The American journal of cardiology·2025

Same author

Right Ventricular Outflow Conduit Stenosis After Childhood Ross-Konno Procedure.

JACC. Case reports·2025

Same author

Oral health care use characteristics in a limited sample of Medicare Advantage beneficiaries, Medicare Advantage Encounter data 2021.

Journal of the American Dental Association (1939)·2025

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

Gender differences in platelet aggregation in healthy individuals.

Mohammad Otahbachi¹, Jan Simoni, Grace Simoni

¹Department of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, USA.

Journal of Thrombosis and Thrombolysis

|December 30, 2009

Summary

Gender significantly influences platelet aggregation, with females exhibiting higher responses to common agonists like collagen compared to males. This finding highlights sex as a key factor in platelet reactivity across diverse ethnicities.

More Related Videos

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Related Experiment Videos

Last Updated: Jun 17, 2026

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Area of Science:

Hematology
Cardiovascular Research
Sex Differences in Physiology

Background:

Platelet aggregation is crucial for hemostasis and thrombosis.
Understanding factors influencing platelet reactivity, such as gender and ethnicity, is vital for cardiovascular health.
Previous research has suggested potential sex-based differences in platelet function, but comprehensive evaluation across multiple agonists and ethnicities is limited.

Purpose of the Study:

To investigate gender-based variations in platelet aggregation.
To assess the impact of common agonists (adenosine-5'-diphosphate, epinephrine, arachidonic acid, collagen) on platelet aggregation in healthy males and females.
To explore potential ethnic influences on gender-related differences in platelet aggregation.

Main Methods:

Ex-vivo measurement of platelet aggregation using a platelet ionized calcium aggregometer.
Inclusion of 36 healthy participants (males and females) across Caucasian, Hispanic, and African-American ethnic groups.
Testing platelet response to adenosine-5'-diphosphate (ADP), epinephrine (EPI), arachidonic acid (AA), and collagen (COL).

Main Results:

Female participants demonstrated significantly higher platelet aggregation responses compared to males across all tested agonists.
The most pronounced gender difference was observed with collagen-induced platelet aggregation (P < 0.01).
Caucasian women exhibited the highest susceptibility to platelet aggregation among all ethnic and gender groups.

Conclusions:

Gender is a significant determinant of platelet aggregability in response to common agonists.
Females generally show heightened platelet reactivity, particularly to collagen, irrespective of ethnicity.
These findings underscore the importance of considering gender in the context of platelet function and cardiovascular risk assessment.